Seoul St. Mary's Hospital Certified as Research-Centric Hospital... Leap to Global Convergence Research Platform

Expansion Centered on "Hematologic and Immunologic Diseases," "Digital Clinical," and "Precision Regenerative Medicine"

Catholic University Seoul St. Mary’s Hospital (the hospital) has been selected as a first-phase certified research-oriented hospital by the Ministry of Health and Welfare. The hospital plans to fully initiate its transition into a global research-oriented hospital based on the convergence of medical care and research by 2028.

The hospital has been striving to establish sustainable research-oriented governance with the vision of becoming a "global research-oriented hospital implementing world-class advanced medical care." To this end, it is pursuing four major goals: ▲establishing governance for healthcare research commercialization ▲building a sustainable research and development commercialization system ▲advancing a commercialization system based on an open platform ▲realizing social value through globally leading research.

The hospital also maximizes the advantage of having the Biomedical Industry Research Institute, POSTECH-Catholic University Biomedical Engineering Research Institute, and the College of Medicine all located within the same complex. Unlike other research-oriented hospitals spatially separated from existing research complexes, the core strategy is to leverage the strengths of an industry-academia-research-hospital complex to swiftly and efficiently carry out the entire process from basic research through convergent research to clinical application.

To this end, the hospital established the "Research-Oriented Hospital Certification Evaluation Project Team" directly under the Vice President for Medical Affairs and the Medical Center Director of the Catholic Central Medical Center, aiming to systematize research governance by integrating and linking the capabilities of the medical center and the College of Medicine. It has strengthened functions related to research execution, research support, and administrative systems.

In particular, the "Omnibus Park," a one-stop cluster where large pharmaceutical companies and promising bio startups reside and enable real-time collaboration among industry, academia, research, and hospitals, opened in May 2022 and has become a focal point.

The hospital plans to focus on seven detailed fields based on three major research platforms known as Seoul St. Mary’s Hospital’s specialized areas: "hematologic and immunologic diseases," "digital clinical," and "precision regenerative medicine." The seven fields are ▲hematologic diseases ▲intractable autoimmune diseases ▲genomics ▲big data artificial intelligence ▲smart medical devices ▲artificial organ organoids ▲cell therapy.

Yoon Seung-gyu, director of Seoul St. Mary’s Hospital, said, "The research infrastructure and global research capabilities we have accumulated so far have been further recognized through the certification as a research-oriented hospital. We will strive to present a new direction for healthcare innovation through creative convergent technology medicine research and contribute to the advancement of personalized medicine and the promotion of public health."

This content was produced with the assistance of AI translation services.